Medtronic ROA 2024

Medtronic ROA

0.04

Medtronic Dividend yield

3.16 %

Ticker

MDT

ISIN

IE00BTN1Y115

WKN

A14M2J

In 2024, Medtronic's return on assets (ROA) was 0.04, a -25.39% increase from the 0.06 ROA in the previous year.

Medtronic Aktienanalyse

What does Medtronic do?

Medtronic PLC is a globally leading medical technology company headquartered in Dublin, Ireland. The company was founded in 1949 by Earl Bakken and Palmer Hermundslie and has since developed a comprehensive portfolio of products in the field of medical devices and equipment. Medtronic's business model is focused on meeting the demand for innovative medical technology to improve the quality of life for patients and treat or alleviate diseases and disorders. The company strives to constantly invest in research and development to bring new and improved products to the market. Medtronic offers an extensive range of products that can be used in the fields of cardiology, neuromodulation, spinal surgery, diabetes, hearing aids, surgery, ophthalmology, infection prevention, percutaneous intervention procedures, and more. One of the most well-known product series is the pacemaker, which has been manufactured by Medtronic in a variety of models since 1957. In the field of neuromodulation, Medtronic is a leader in the development of implants that can treat various disorders of the nervous system. This includes deep brain stimulation (DBS) for Parkinson's disease, as well as spinal cord stimulation procedures for chronic pain and neurostimulation procedures for bladder, bowel, and gastrointestinal disorders.. In the field of spinal medicine, Medtronic offers a variety of devices that contribute to the stabilization of the spine and can be implemented through minimally invasive procedures. These include products such as plate systems, cages, spinal stabilizations, chamber drains, medication pumps, and more. In the field of diabetes, Medtronic focuses on the development of insulin pump systems that allow for more precise administration of insulin. The system also includes a sensor that continuously monitors blood sugar levels and can trigger insulin delivery as needed. Medtronic is also known for its efforts in infection prevention, offering products such as antimicrobial catheters, wound care, and hospital hygiene solutions. In addition to its products, the company is also involved in medical education and consulting. As part of these efforts, Medtronic develops training and education programs for physicians and healthcare personnel to enhance techniques and the use of devices and systems. Over the years, Medtronic has expanded its product offering through mergers and acquisitions. Currently, the company employs over 86,000 people in locations across more than 160 countries worldwide. Overall, Medtronic aims to drive innovation in medical technology and enable better healthcare for patients worldwide through its products and services. Medtronic ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Medtronic's Return on Assets (ROA)

Medtronic's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Medtronic's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Medtronic's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Medtronic’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Medtronic Stock

What is the Return on Assets (ROA) of Medtronic this year?

The Return on Assets (ROA) of Medtronic is 0.04 undefined this year.

What was the ROA of Medtronic compared to the previous year?

The ROA of Medtronic has increased by -25.39% compared to the previous year.

What consequences do high ROA have for investors of Medtronic?

A high ROA is advantageous for investors of Medtronic, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Medtronic?

A low ROA can be unfavorable for investors of Medtronic as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Medtronic affect the company?

An increase in ROA of Medtronic can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Medtronic impact the company?

A reduction in the ROA of Medtronic can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Medtronic?

Some factors that can influence the ROA of Medtronic include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Medtronic important for investors?

The ROA of Medtronic is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Medtronic take to improve ROA?

To improve ROA, Medtronic can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Medtronic pay?

Over the past 12 months, Medtronic paid a dividend of 2.75 USD . This corresponds to a dividend yield of about 3.16 %. For the coming 12 months, Medtronic is expected to pay a dividend of 2.81 USD.

What is the dividend yield of Medtronic?

The current dividend yield of Medtronic is 3.16 %.

When does Medtronic pay dividends?

Medtronic pays a quarterly dividend. This is distributed in the months of July, October, January, April.

How secure is the dividend of Medtronic?

Medtronic paid dividends every year for the past 48 years.

What is the dividend of Medtronic?

For the upcoming 12 months, dividends amounting to 2.81 USD are expected. This corresponds to a dividend yield of 3.24 %.

In which sector is Medtronic located?

Medtronic is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medtronic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medtronic from 4/12/2024 amounting to 0.69 USD, you needed to have the stock in your portfolio before the ex-date on 3/21/2024.

When did Medtronic pay the last dividend?

The last dividend was paid out on 4/12/2024.

What was the dividend of Medtronic in the year 2023?

In the year 2023, Medtronic distributed 2.67 USD as dividends.

In which currency does Medtronic pay out the dividend?

The dividends of Medtronic are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Medtronic stock can be added to a savings plan with the following providers: Scalable Capital and Consorsbank

Andere Kennzahlen von Medtronic

Our stock analysis for Medtronic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medtronic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.